Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Efficacy and Safety of Radiofrequency Ablation Under Endoscopic Ultrasonography Guidance in Pancreatic Neuroendocrine and Cystic Tumor

NCT02330497 is registered in ClinicalTrials.gov with Société Française d'Endoscopie Digestive as lead sponsor.

NCT NCT02330497
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02330497 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Efficacy and Safety of Radiofrequency Ablation Under Endoscopic Ultrasonography Guidance in Pancreatic Neuroendocrine and Cystic Tumor
Lead sponsor
Société Française d'Endoscopie Digestive
Phase
Not applicable
Overall status
Completed
Start date
February 28, 2015
Completion date
February 28, 2017
Enrollment
30 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

endocrine tumor, neoplasms, cystic, mucinous, and serous, pancreatic tumor